-
Americans Don't Really Understand The Zika Virus
Wednesday, March 30, 2016 - 1:59pm | 368Read More...A new Harvard poll has found that the majority of Americans are misinformed about the risks of Zika virus, and sizable minority mistakenly believe that Zika virus is transmitted by coughing and sneezing. About one in five (22 percent) are not aware that Zika virus can be transmitted from mother...
-
American Vanguard Is A Niche Player In Ag Chemicals
Friday, March 11, 2016 - 9:48am | 329Read More...ROTH Capital’s Joe Reagor initiated coverage on American Vanguard Corp. (NYSE: AVD) with a Buy rating and price target of $19. A Niche Player “We believe AVD is a unique niche player in the agricultural chemicals market and that the company is poised for additional growth in the...
-
Thermo Fisher To Offer Anti-Zika Virus Test Kits, Notes First Tests Available In US
Tuesday, February 23, 2016 - 8:51am | 202Read More...Thermo Fisher Scientific Inc. (NYSE: TMO) announced on Monday that it is now offering consumers a test kit to enable detection of the Zika virus in research applications. Thermo Fisher noted that its test is the first of its kind available in the US. The company added that its test also enables...
-
Inovio Reports Encouraging Results From Preclinical Testing Of Zika Virus Vaccine
Wednesday, February 17, 2016 - 11:52am | 253Read More...Shares of Inovio Pharmaceuticals Inc (NASDAQ: INO) were trading higher by more than 5 percent on Wednesday after the company announced that preclinical testing of SynCon, a vaccine for the Zika virus, induced "robust and durable immune responses." Inovio is developing a vaccine for...
-
Intrexon Can Make Hundreds Of Millions From Zika Virus Treatment
Wednesday, February 17, 2016 - 10:12am | 313Read More...Intrexon Corp (NYSE: XON) shares have been volatile in recent months and are down 36 percent since August 17. Wunderlich’s Rob Breza maintained a Buy rating for the company, with a price target of $50. Intrexon’s efforts to set up a facility to combat the Zika virus and...
-
EXCLUSIVE: Inovio Plans On Producing Zika Vaccine By Q3 2016, Ready For Phase 1 Study By Q4
Friday, January 29, 2016 - 2:38pm | 454Read More...Inovio Pharmaceuticals Inc (NASDAQ: INO) plans to complete its testing of a Zika vaccine in mice and monkeys by the third quarter of this year before moving to a Phase 1 study in Q4, a company spokesperson told Benzinga. The company said it plans to produce between 5,000 and 10,000 doses by Q3...
-
Why Are Airline Stocks Getting Hurt By Zika Pandemic Fears?
Friday, January 29, 2016 - 12:26pm | 272Read More...While the Zika Virus outbreak in South America may seem isolated from the U.S. economy to this point, consumer fears have already begun impacting the airline industry. In a new report, Raymond James analyst Savanthi Syth takes a look at which airlines could be impacted the most and how much Zika...
-
EXCLUSIVE: Colombian Health Minister Says Country Has 16,490 Confirmed Zika Cases, Likely More Unreported
Friday, January 29, 2016 - 11:20am | 315Read More...Although Brazil is the epicenter of the fears surrounding a recent outbreak of Zika Virus, Colombia’s Health Minister Alejandro Gaviria told Benzinga via email that Colombia now has 16,490 confirmed cases of the disease and there are likely thousands more unreported cases as well. Zika is...
-
Promising Zika Research Fuels Cerus Stock Surge
Thursday, January 28, 2016 - 4:54pm | 468Read More...Shares of Cerus Corporation (NASDAQ: CERS) were trading up 4.2 percent Thursday as news of research that successfully inactivated the Zika virus in human blood circulated among traders. BTIG analysts Karen Koski, Dr. Sean Lavin and Andrea Alfonso reiterated their "buy" rating for...
-
Stocks To Play In A Zika Virus Pandemic
Thursday, January 28, 2016 - 2:25pm | 341Read More...In a new article from the Journal of the American Medical Association, scientists Daniel Lucey and Lawrence Gostin urge the World Health Organization (WHO) to take urgent action to combat the Zika virus. There is currently no vaccine for the virus, which is linked to shrunken brains in children....
-
Intrexon Spikes 20%; Oxitec Subsidiary Working To Control Zika Virus Outbreak
Thursday, January 28, 2016 - 1:34pm | 196Read More...Shares of Intrexon Corp (NYSE: XON) were trading higher by more than 12 percent at $29.69 early Thursday afternoon. Intrexon is engaged in the field of synthetic biology. The company designs, builds and regulates gene programs which are Deoxyribonucleic Acid (DNA) sequences that consist of...
